Cambridge Science Park nudges forward with pea-based plastics and AI robotics When AstraZeneca paused plans to invest £200 million in Cambridge last year, the news stirred questions about the region’s research vitality and its ability to attract big-ticket funding. Yet the Cambridge Science Park has continued to evolve, diversifying beyond traditional biotech labs toward a…